TL
AGN

TrueWealth LLC’s Allergan plc AGN Stock Holding History

TrueWealth LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-199
Closed -$35K – 800
2020
Q1 		$35K Sell
199
-49
-20% -$9.23K 0.02% 290
2019
Q4 		$47K Hold
248
– – 0.02% 281
2019
Q3 		$42K Hold
248
– – 0.02% 284
2019
Q2 		$42K Buy
248
+122
+97% +$16.9K 0.02% 286
2019
Q1 		$18K Hold
126
– – 0.01% 378
2018
Q4 		$17K Hold
126
– – 0.01% 376
2018
Q3 		$24K Hold
126
– – 0.01% 368
2018
Q2 		$21K Hold
126
– – 0.01% 385
2018
Q1 		$21K Buy
126
+8
+7% +$1.34K 0.01% 356
2017
Q4 		$19K Buy
+118
New +$21.2K 0.01% 406

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

TrueWealth LLC's AGN Position: Q2 2020 in Review

TrueWealth LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 199 shares — an estimated $35K sold.

TrueWealth LLC first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $47K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • TrueWealth LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • TrueWealth LLC sold 199 Allergan plc shares in Q2 2020, an estimated $35K.
  • TrueWealth LLC first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • TrueWealth LLC's Allergan plc position peaked at $47K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.